Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Nishimura

Showing results (381-390 of 428) with videos related to

Pageof 43
Sort By:
Oncogene|April 4, 2017
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4N Ueno, N Nishimura, S Ueno, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 1999
Increases in plasma ouabainlike immunoreactivity during surgical extirpation of pheochromocytomaY Komiyama, N Nishimura, M Munakata, et al.
Arzneimittel-Forschung|February 1, 1988
General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systemsT Saito, T Fukuda, S Tajima, et al.
Journal of Medicinal Chemistry|October 1, 1982
Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivativesT Kametani, K Kigasawa, M Hiiragi, et al.
Gastroenterologia Japonica|July 1, 1991
Hepatitis C virus infection in patients with chronic liver diseasesM Yoshikawa, T Tsujii, H Fukui, et al.
Journal of Cardiology|January 1, 1992
[Hemodynamic difference accounted for the orientation of a Björk-Shiley mitral prosthesis: a color Doppler echocardiographic study]Y Jin-Nouchi, Y Doi, H Odawara, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisT Bohgaki, Y Amasaki, N Nishimura, et al.
Cancer Letters|April 15, 2023
m<sup>6</sup>A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibitionAngelica Benavides-Serrato, Jacquelyn T Saunders, Sunil Kumar, et al.
Annals of the Entomological Society of America|September 21, 2010
Differential Survivorship of Invasive Mosquito Species in South Florida Cemeteries: Do Site-Specific Microclimates Explain Patterns of Coexistence and Exclusion?L P Lounibos, G F O'Meara, S A Juliano, et al.
Journal of Drug Targeting|April 13, 2005
An intracellular delivery vehicle for protein transduction of micro-dystrophinRichard H Weisbart, James E Hansen, Robert N Nishimura, et al.
Pageof 43

Showing results (381-390 of 428) with videos related to

Sort By:
Pageof 43
Oncogene|April 4, 2017
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4N Ueno, N Nishimura, S Ueno, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 1999
Increases in plasma ouabainlike immunoreactivity during surgical extirpation of pheochromocytomaY Komiyama, N Nishimura, M Munakata, et al.
Arzneimittel-Forschung|February 1, 1988
General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systemsT Saito, T Fukuda, S Tajima, et al.
Journal of Medicinal Chemistry|October 1, 1982
Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivativesT Kametani, K Kigasawa, M Hiiragi, et al.
Gastroenterologia Japonica|July 1, 1991
Hepatitis C virus infection in patients with chronic liver diseasesM Yoshikawa, T Tsujii, H Fukui, et al.
Journal of Cardiology|January 1, 1992
[Hemodynamic difference accounted for the orientation of a Björk-Shiley mitral prosthesis: a color Doppler echocardiographic study]Y Jin-Nouchi, Y Doi, H Odawara, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisT Bohgaki, Y Amasaki, N Nishimura, et al.
Cancer Letters|April 15, 2023
m<sup>6</sup>A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibitionAngelica Benavides-Serrato, Jacquelyn T Saunders, Sunil Kumar, et al.
Annals of the Entomological Society of America|September 21, 2010
Differential Survivorship of Invasive Mosquito Species in South Florida Cemeteries: Do Site-Specific Microclimates Explain Patterns of Coexistence and Exclusion?L P Lounibos, G F O'Meara, S A Juliano, et al.
Journal of Drug Targeting|April 13, 2005
An intracellular delivery vehicle for protein transduction of micro-dystrophinRichard H Weisbart, James E Hansen, Robert N Nishimura, et al.
Pageof 43